Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-065749
Filing Date
2017-03-01
Accepted
2017-03-01 16:17:05
Documents
70
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d285960d10k.htm 10-K 986877
2 EX-10.3 d285960dex103.htm EX-10.3 198491
3 EX-21.1 d285960dex211.htm EX-21.1 715
4 EX-23.1 d285960dex231.htm EX-23.1 2978
5 EX-31.1 d285960dex311.htm EX-31.1 6369
6 EX-31.2 d285960dex312.htm EX-31.2 6476
7 EX-32.1 d285960dex321.htm EX-32.1 4679
14 GRAPHIC g285960g78r06.jpg GRAPHIC 122994
15 GRAPHIC g285960g97z07.gif GRAPHIC 9323
  Complete submission text file 0001193125-17-065749.txt   4834200

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT itci-20161231.xml EX-101.INS 813296
9 XBRL TAXONOMY EXTENSION SCHEMA itci-20161231.xsd EX-101.SCH 41948
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20161231_cal.xml EX-101.CAL 68133
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20161231_def.xml EX-101.DEF 127465
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20161231_lab.xml EX-101.LAB 384505
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20161231_pre.xml EX-101.PRE 270201
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 17654339
SIC: 2834 Pharmaceutical Preparations